Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim. - Wikidata - wikimedia - TriplyDB

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

http://www.wikidata.org/entity/Q33406819

about

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study.

P2860

Q33442354-4432D731-2186-4C53-968E-6D2B0F06C21F Q47093315-DF13BE5F-F4C7-477B-8C03-5F708443DF91

P2860

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

http://www.wikidata.org/entity/Q33406819

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

@ast

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

@en

type

label

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

@ast

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

@en

prefLabel

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

@ast

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

@en

P1433

Q33406819-2B420BE6-6051-4016-8170-669061E46B71

P1476

Q33406819-464907F1-10BC-44A3-8073-5952E6A791F0

P2093

Q33406819-5C5CE6E7-B5F1-4997-B426-329FEE6DDA6C

Q33406819-62D844F3-3B30-4CA8-BF07-B60190D98F49

Q33406819-76767BAB-B9AE-49AF-83A9-52F6746276C4

Q33406819-7EE86D56-BC3E-48A8-9B6E-D4157E21B356

Q33406819-A937E9D3-BB61-480B-A647-D6A5DF6A6462

P2860

Q33406819-00743858-8D62-4123-ADD7-F7B5B275A467

Q33406819-05398595-6525-46EE-A732-3EF578C96810

Q33406819-057085DA-0DCF-49C3-B74C-EABD4D0D48E0

Q33406819-166CCB57-29F2-435B-A41C-D3BC2FBC1F1E

Q33406819-21CE39E2-4B62-4845-80B8-9E93EF77C8D8

Q33406819-234A2E0F-C8A9-42A7-A015-A91FF9102F98

Q33406819-25AC8332-B16B-4FD0-95BB-D5F5B1B21DCE

Q33406819-2E646547-F6CF-4F39-8E3A-A950E1A8428B

Q33406819-3236A66E-98C9-4512-841D-CFF9BD770F96

Q33406819-3B71DB34-950D-4BC6-B197-4F22319C55E9

P304

Q33406819-7681342C-B53D-448E-9A8D-08B53A0605C3

P31

Q33406819-DBBEC5ED-8C8C-432D-A9D3-E751BE5AC9BF

P356

Q33406819-0750620E-DEE4-4E6C-AEA3-3A180D2884B3

P433

Q33406819-BC475C2F-5C28-44DE-8D62-120168906F98

P478

Q33406819-9C4C5835-A351-44E3-828D-B36F50711118

P577

Q33406819-6155F7A0-057F-4041-B0BE-2878A1DF2456

P698

Q33406819-11CCDE55-6A19-4ACB-A3B8-E2790728A389

P356

0961203313477900

P1433

P1476

Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

@en

P2093

E T Bruner

http://www.w3.org/2001/XMLSchema#string

J Lazarchick

http://www.w3.org/2001/XMLSchema#string

M N Budisavljevic

http://www.w3.org/2001/XMLSchema#string

S E Self

http://www.w3.org/2001/XMLSchema#string

S Tomov

http://www.w3.org/2001/XMLSchema#string

P2860

Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes

Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients?

Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study.

Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis.

Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.

Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement.

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.

Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus.

Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura.

P304

504-509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203313477900

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23554039

http://www.w3.org/2001/XMLSchema#string